We reviewed studies this past year that further characterize the epidemiology, etiology and
risk stratification of acute pancreatitis. Evolving areas include chemoprevention of post …

Recent randomized controlled trials in acute pancreatitis have provided evidence that
challenges current approaches to management, including fluid resuscitation, antibiotic …

Acute pancreatitis is a disease of variable severity that can lead to significant morbidity and
mortality. Current management has remained limited to supportive measures and the …

In the past decade, a significant amount of active and enthusiastic research has changed the
way we treat acute pancreatitis (AP) within the first 24 hours of presentation. We highlight the …

Acute pancreatitis is a disease of increasing prevalence, unchanged mortality over many
decades, and limited treatment strategies. Progress has been made in developing therapies …

There is still no proven effective disease-specific pharmacologic therapy that changes the
natural history of acute pancreatitis. New therapeutic targets and pharmacologic agents are …

While conservative management such as fluid, bowel rest, and antibiotics is the mainstay of
current acute pancreatitis management, there is a lot of promise in pharmacologic therapies …

This review highlights advances made in recent years in the diagnosis and management of
acute pancreatitis (AP). We focus on epidemiological, clinical, and management aspects of …

Purpose of review Despite the increasing incidence of acute pancreatitis, the overall
mortality of AP has decreased. Recent findings The findings of recent studies on fluid …

(AGA) on the initial management of acute pancreatitis (AP). The guideline was developed by
the AGA's Clinical Practice Guideline Committee and approved by the AGA Governing …